UK biotech leaders demand government investment for its survival
This article was originally published in Scrip
Executive Summary
Sir Christopher Evans, head of the biotech fund manager Excalibur, and 21 other leading figures in UK biotech are calling on the UK government to make significant investment in the sector to ensure its survival.